美因基因(06667.HK)接獲復牌指引 繼續停牌
格隆匯5月30日丨美因基因(06667.HK)公告,於2025年5月23日,公司從聯交所收到以下復牌指引:(i)就公司日期爲2025年4月1日及2025年4月22日的公告所披露有關基因檢測試劑盒業務確認收入以及推廣開支及預付款的審計問題進行適當的獨立法證調查,評估對公司業務營運及財務狀況的影響,公佈調查結果,並採取適當的補救措施;(ii)證明對集團管理層及╱或對公司管理及營運具有重大影響力的任何人士的誠信、能力及╱或品格並無合理的監管疑慮,以致可能對投資者構成風險及損害市場信心;(iii)進行獨立內部控制審覈,證明公司已制定充足的內部控制及程序,以履行其上市規則項下的義務;(iv)刊發上市規則規定的所有尚未刊發財務業績,並處理任何審計修改;(v)確認公司的操作符合上市規則13.24;及(vi)向市場公佈所有重大信息,以供公司股東及其他投資者評估其狀況。繼續暫停買賣。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.